ImmunityBio, Inc. Patent Application Trends in 2025

ImmunityBio, Inc. patent applications in 2025

Top 10 Technology Areas

• A61K45/06 (Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca)
  • Count: 4 patents
  • Example: 20250066484. Anti-B7-H4 Chimeric Antigen Receptor-Modified NK-92 Cells (ImmunityBio, Inc.)
• C12N5/0646 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media)
  • Count: 4 patents
  • Example: 20250066484. Anti-B7-H4 Chimeric Antigen Receptor-Modified NK-92 Cells (ImmunityBio, Inc.)
• C07K16/2827 (PEPTIDES (peptides in foodstuffs)
  • Count: 3 patents
  • Example: 20250066484. Anti-B7-H4 Chimeric Antigen Receptor-Modified NK-92 Cells (ImmunityBio, Inc.)
• A61K39/4613 ({Cellular immunotherapy})
  • Count: 3 patents
  • Example: 20250066484. Anti-B7-H4 Chimeric Antigen Receptor-Modified NK-92 Cells (ImmunityBio, Inc.)
• C07K14/5443 (PEPTIDES (peptides in foodstuffs)
  • Count: 3 patents
  • Example: 20250066484. Anti-B7-H4 Chimeric Antigen Receptor-Modified NK-92 Cells (ImmunityBio, Inc.)
• C07K2319/30 (PEPTIDES (peptides in foodstuffs)
  • Count: 3 patents
  • Example: 20250042971. LAIR-2 Compositions and Methods (ImmunityBio, Inc.)
• A61P35/00 (Antineoplastic agents)
  • Count: 2 patents
  • Example: 20250066484. Anti-B7-H4 Chimeric Antigen Receptor-Modified NK-92 Cells (ImmunityBio, Inc.)
• C07K14/70521 (PEPTIDES (peptides in foodstuffs)
  • Count: 2 patents
  • Example: 20250066484. Anti-B7-H4 Chimeric Antigen Receptor-Modified NK-92 Cells (ImmunityBio, Inc.)
• C07K14/70535 (PEPTIDES (peptides in foodstuffs)
  • Count: 2 patents
  • Example: 20250066484. Anti-B7-H4 Chimeric Antigen Receptor-Modified NK-92 Cells (ImmunityBio, Inc.)
• C07K2319/03 (PEPTIDES (peptides in foodstuffs)
  • Count: 2 patents
  • Example: 20250066484. Anti-B7-H4 Chimeric Antigen Receptor-Modified NK-92 Cells (ImmunityBio, Inc.)

Emerging Technology Areas

• C12N2501/2304 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media)
  • Count: 1 patents
  • Example: 20250011718. Ex Vivo Generation of Immune Effector Cells from Apheresis Material Intermediates (ImmunityBio, Inc.)
• C12N2501/22 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media)
  • Count: 1 patents
  • Example: 20250011718. Ex Vivo Generation of Immune Effector Cells from Apheresis Material Intermediates (ImmunityBio, Inc.)
• A61K39/464499 ({Cellular immunotherapy})
  • Count: 1 patents
  • Example: 20250011718. Ex Vivo Generation of Immune Effector Cells from Apheresis Material Intermediates (ImmunityBio, Inc.)
• A61K39/4611 ({Cellular immunotherapy})
  • Count: 1 patents
  • Example: 20250011718. Ex Vivo Generation of Immune Effector Cells from Apheresis Material Intermediates (ImmunityBio, Inc.)
• C12N5/0636 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media)
  • Count: 1 patents
  • Example: 20250011718. Ex Vivo Generation of Immune Effector Cells from Apheresis Material Intermediates (ImmunityBio, Inc.)
• C07K2317/73 (PEPTIDES (peptides in foodstuffs)
  • Count: 1 patents
  • Example: 20250011380. METHODS OF TREATING AGING-RELATED DISORDERS (ImmunityBio, Inc.)
• C07K2317/24 (PEPTIDES (peptides in foodstuffs)
  • Count: 1 patents
  • Example: 20250011380. METHODS OF TREATING AGING-RELATED DISORDERS (ImmunityBio, Inc.)
• C07K14/4703 (PEPTIDES (peptides in foodstuffs)
  • Count: 1 patents
  • Example: 20250011380. METHODS OF TREATING AGING-RELATED DISORDERS (ImmunityBio, Inc.)
• C12N2510/00 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media)
  • Count: 1 patents
  • Example: 20250084175. GENERATION OF CHIMERIC ANTIGEN RECEPTOR mRNA MOLECULES FOR EXPRESSION IN PRIMARY NK CELLS (IMMUNITYBIO, INC.)
• C07K2319/02 (PEPTIDES (peptides in foodstuffs)
  • Count: 1 patents
  • Example: 20250084175. GENERATION OF CHIMERIC ANTIGEN RECEPTOR mRNA MOLECULES FOR EXPRESSION IN PRIMARY NK CELLS (IMMUNITYBIO, INC.)

Top Inventors

• Patrick Soon-Shiong of Culver City CA (US) (4 patents)
• Hing C. Wong of Miramar FL (US) (2 patents)
• Hans G. Klingemann of Culver City CA (US) (1 patent)
• Laurent H. Boissel of Culver City CA (US) (1 patent)
• Patrick SOON-SHIONG of Los Angeles CA (US) (1 patent)
• Hans G Klingemann of Culver City CA (US) (1 patent)
• Laurent H Boissel of Culver City CA (US) (1 patent)
• Himani Chinnapen of Culver City CA (US) (1 patent)
• Abhijit Dandapat of Culver City CA (US) (1 patent)
• Fereshteh PARVIZ of Culver City CA (US) (1 patent)

Patent Categories

Geographical Distribution of Inventors

Error creating thumbnail: File missing

Geographical Distribution of US Inventors

Error creating thumbnail: File missing